ecrin-mdr-crcClinical2010Colorectal CancerColorectal NeoplasmsCáncer colorrectal avanzadoColorectal CancerColorectal NeoplasmsCáncer Colorrectal AvanzadoInterventionalhttps://newmdr.ecrin.org/Study/2085155Spain2OxaliplatinoIrinotecanCapecitabinaOxaliplatin5FUCapecitabine5-fluorouraciloBevacizumabFluorouracilECRIN MDRCompletedfalseSelecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal CancerThe purpose of the study is to evaluate the efficacy and safety of the capecitabine or 5-fluorouracil selection, according to polymorphisms in TS-3’UTR and ERCC1-118, to be combined with oxaliplatin or irinotecan as first-line chemotherapy in advanced colorectal cancer2010-02-152085155NCT010716552009-012562-31